KLOTRIX Drug Patent Profile
✉ Email this page to a colleague
When do Klotrix patents expire, and what generic alternatives are available?
Klotrix is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in KLOTRIX is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Klotrix
A generic version of KLOTRIX was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
Summary for KLOTRIX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 314 |
Patent Applications: | 2,341 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KLOTRIX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for KLOTRIX
US Patents and Regulatory Information for KLOTRIX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | KLOTRIX | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 017850-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for KLOTRIX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Apothecon | KLOTRIX | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 017850-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |